In this article, we will discuss Claude Stock Portfolio: Top 5 Stocks to Buy According to AI Chatbot. Please visit Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot, if you would like to see the extended list and the methodology behind it.

5. Reddit Inc (NYSE:RDDT)

Number of Hedge Funds: 82

Claude picked Reddit Inc (NYSE:RDDT) as one of its top stock ideas despite Wall Street worries that AI chatbots could hurt the platform by giving users answers directly instead of sending them to Reddit. Claude argued bears were missing the bigger story: Reddit’s growing AI data-licensing business. Google has reportedly agreed to pay Reddit about $60 million annually to use Reddit data for training Gemini AI models, while OpenAI has also partnered with the company to bring Reddit content into ChatGPT products.

Claude also pointed to Reddit’s April 30 earnings report as a potential catalyst for a post-results rally due to high short interest in the stock. That call proved correct. Reddit shares jumped in after-hours trading after the company posted stronger-than-expected first-quarter results, helped by a 74% surge in advertising revenue. Revenue rose 69% year over year to $663 million, while earnings of $1.01 per share easily topped Wall Street estimates. Reddit Inc (NYSE:RDDT) also issued second-quarter revenue guidance above analyst expectations.

Carillon Eagle Mid Cap Growth Fund stated the following regarding Reddit, Inc. (NYSE:RDDT) in its Q1 2026 investor letter:

“Reddit, Inc. (NYSE:RDDT) is an online community platform where users share, discuss, and engage with content across a wide range of topics. The company posted solid revenue growth and profitability, while the closely watched metric of logged-in user growth was somewhat disappointing. Additional uncertainty around upcoming large language model (LLM) data-licensing renewals also pressured sentiment. The company authorized a stock buyback and provides an appealing audience for advertisers, as roughly half of its users are not active on other social media platforms.”

4. Vistra Corp (NYSE:VST)

Number of Hedge Funds: 102

Vistra Corp (NYSE:VST) is among the biggest holdings in Claude’s May 2026 portfolio. Its thesis is simple: the AI revolution is driving massive electricity demand as data centers require huge amounts of power. Claude believes Vistra is positioned to benefit because it operates power generation assets within the ERCOT and PJM power markets, two of the largest U.S. electricity grids serving states including Texas and much of the Eastern U.S.

The AI chatbot also pointed to Vistra Corp’s (NYSE:VST) nuclear power agreement with Meta Platforms and the planned restart of its Perry nuclear plant.

Claude said its probability-weighted 12-month price target for Vistra is $184, based on a bull-case scenario of $230 and a bear-case scenario of $125.

Brown Advisory Mid-Cap Growth Strategy stated the following regarding Vistra Corp. (NYSE:VST) in its fourth quarter 2025 investor letter:

“Vistra Corp. (NYSE:VST): Operates as a retail electricity and power generation company. Vistra (VST) benefited from rising power demand in Texas, increased interest from data center customers in directly sourcing generation, and growing investor appreciation for nuclear assets. During the year, the company signed a large power purchase agreement with a major hyperscaler for its Comanche Peak nuclear facility in Texas, and we see the potential for additional large deals in the future.”

3. ServiceNow (NYSE:NOW)

Number of Hedge Funds: 118

Wall Street has been skeptical about ServiceNow (NYSE:NOW) amid concerns that AI disruption could hurt the company’s long-term growth. The bear case argues that AI agents could eventually replace parts of ServiceNow’s software over time. Anthropic’s AI model Claude recently addressed those concerns, saying it assigns a 20% probability to that bear case but remains bullish on the stock.

Claude argued that ServiceNow (NYSE:NOW) is becoming more important in the AI era because its software acts as the control center connecting enterprise workflows and systems used by AI agents. Claude also said ServiceNow’s Now Assist AI offering is monetizing through additional seat pricing rather than replacing its core platform. The AI model added that ServiceNow’s roughly 18x fiscal 2027 earnings multiple already reflects execution concerns, compared with its five-year average valuation near 35x and peer SaaS companies trading around 25x.

ServiceNow (NYSE:NOW) CEO recently said the company believes reaching $30B in subscription revenue by 2030 is the “bear case.” Last year, the company’s subscription revenue came in at about $12.8 billion.

ServiceNow (NYSE:NOW) is the largest holding in Claude AI portfolio, according to The Claude Portfolio Twitter account.

Polen Focus Growth Strategy stated the following regarding ServiceNow, Inc. (NYSE:NOW) in its Q1 2026 investor letter:

“As agents need access to a company’s mission critical software, the software companies may be able to monetize agentic users just as they do human ones. Companies like Microsoft, ServiceNow, Inc. (NYSE:NOW), Shopify, Oracle, CoStar and Synopsys all have multiple moats and, in each case, we see generative AI as a tailwind for their businesses, not a headwind. We believe the selloff in these businesses in the quarter presented us with attractive buying opportunities in many of the high-quality businesses we own. We also sold Adobe, Intuit and Paycom to redeploy the capital to our highest conviction software names like ServiceNow , Shopify and CoStar Group . The previously discussed price dislocations within the software space have presented opportunities for long term patient investors and we believe it prudent to consolidate some of the portfolio around businesses where we believe the AI disruption concerns are excessive and are unlikely to materially affect their moat. ServiceNow, Shopify and CoStar Group are those types of businesses, in our opinion.

These companies are heavily intertwined into their customers’ workflow (and thus difficult to replace), process/house important data and offer their own enhanced AI solutions. In the case of ServiceNow and Shopify, we believe their respective customers are likely to use their proprietary AI tools rather than try to re-create their own or outsource to an unproven third-party. Both ServiceNow and Shopify are already growing rapidly and we believe have wide open growth potential in enormous markets and AI should be a tailwind for them. We expect these three companies to be among the fastest earnings growers in the Portfolio over the next five years.”

2. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Funds: 137

Eli Lilly and Company (NYSE:LLY) is among the top stock picks of the Claude AI chatbot in 2026. It likes Eli Lilly and Company because it believes the company has stronger long-term advantages in the obesity drug market. It said Eli Lilly and Company (NYSE:LLY) controls about 60% of the U.S. obesity-drug market, while Novo Nordisk, despite being the cheaper stock, is losing market share and posted negative revenue growth. Claude also highlighted that Lilly has a U.S. trade and tariff exemption through January 2029 that Novo does not have. In addition, it believes Eli Lilly and Company (NYSE:LLY) has a stronger pipeline of future drugs, including oral GLP-1 treatments, and better upcoming trial readouts.

Baron Health Care Fund stated the following regarding Eli Lilly and Company (NYSE:LLY) in its Q1 2026 investor letter:

“Eli Lilly and Company (NYSE:LLY), a global pharmaceutical company currently best known for its GLP-1 treatments for diabetes and obesity, detracted from performance. Following a robust fourth quarter of 2025, shares declined after competitor Novo Nordisk launched its oral Wegovy ahead of Lilly’s oral launch in April 2026. Early prescription trends for oral Wegovy have been strong, prompting investor concerns about potential cannibalization of injectable obesity medications and the possibility of price cuts from Novo Nordisk igniting a price war. Novo Nordisk currently offers introductory cash-pay rates on the starting doses ($149 for oral, $199 for injectable), but patients can only access these promotional prices for two months, the discounts apply only to low starting doses that do not drive meaningful weight loss, and most patients ultimately titrate to higher-priced maintenance doses. Longer term, we continue to view Lilly’s Mounjaro and Zepbound, along with its oral GLP-1 orforglipron, as best-in-class treatment options for diabetic and obese patients. We expect GLP 1 therapies to become the standard of care and to represent a $150-billion-plus market opportunity.”

1. Broadcom Inc (NASDAQ:AVGO)

Number of Hedge Funds: 202

Broadcom Inc (NASDAQ:AVGO) is one of Claude’s top AI stock picks. The reasoning is straightforward: Claude believes Broadcom controls about 60% to 70% of the custom AI chip, or ASIC, market thanks to its relationships with major cloud companies. It also highlighted reports that Apollo Global Management and Blackstone are in talks to provide roughly $35 billion in financing tied to Broadcom Inc’s (NASDAQ:AVGO) long-term AI chip contracts with Google through 2031, which Claude viewed as a sign that large financial firms see those contracts as reliable long-term cash-flow assets.

Claude said in a May 11 post that Broadcom Inc (NASDAQ:AVGO) makes up about 3.9% of its portfolio and that the stock had gained roughly 33% since its April 7 entry point. However, it also flagged risks, including Broadcom’s high valuation at around 80 times trailing earnings, the possibility that a rumored $18 billion OpenAI-related deal could be delayed or collapse, and the risk that AI spending from companies like Google and Meta Platforms could slow.

Claude recommended holding the stock through Broadcom Inc’s (NASDAQ:AVGO) earnings report scheduled for June 3, but said investors should “kill” the position if problems around the OpenAI deal grow into a broader long-term issue for the AI financing chain. Claude’s bull-case price target for Broadcom over the next 12 months is $550, while its bear-case target is $325.

Clearbridge Dividend Strategy stated the following regarding Broadcom Inc. (NASDAQ:AVGO) in its Q1 2026 investor letter:

“In IT, we exited Oracle and trimmed Broadcom Inc. (NASDAQ:AVGO). On the semiconductor side, we modestly reduced our position in Broadcom to fund our new investment in Taiwan Semiconductor (TSMC). While Broadcom remains well positioned, and we remain constructive on the stock, the risk-reward outlook has diminished as the shares have tripled over the last two years. Further, whereas TSMC prospers regardless of who wins the semiconductor race (TSMC manufacturers chips for all the major semiconductor companies), one can conceive of scenarios where Broadcom could become less relevant in the future.”

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.